Miicro, Inc.

Chicago, IL 60607

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $993K
First Award Date 09/15/97
Most Recent Award Date 04/01/05

Key Personnel

Last Name Name Awards Contact
Brown Terry F Brown 5

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-27
Budget: 04/01/05 - 03/31/06

DESCRIPTION (provided by applicant): The proposed project focuses upon the development of a robust translational model enabling the early assessment and identification of novel, improved therapeutics for neuropsychiatric illnesses. Such a model has the potential to reduce the substantial gap between currently utilized animal models and the human...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-27
Budget: 04/08/04 - 03/31/05

DESCRIPTION (provided by applicant): The proposed project focuses upon the development of a robust translational model enabling the early assessment and identification of novel, improved therapeutics for neuropsychiatric illnesses. Such a model has the potential to reduce the substantial gap between currently utilized animal models and the human...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/00 - 12/31/03

The majority of CNS compounds dropped from clinical trials are abandoned due to an inability to demonstrate efficacy ill the target patient population These failures are often linked to the selection of in appropriate doses for investigation. This often necessitates the design and initiation of additional studies, resulting in significant delays...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/99 - 04/30/00

APPLICANT'S DESCRIPTION: Modification of regional brain glucose metabolism has been shown to occur with different classes of psychopharmacological compound. Different sites of localization and quantitative effects have been demonstrated using PET under controlled behavioral conditions. We propose to examine the sensitivity of this method by a wi...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/97 - 03/28/98

The objective of this work is to advance CNS drug development by the transfer of novel metabolic imaging technology for application during Phase I and Phase II clinical trials. In this application the plasma dose curve and associated metabolic tissue changes will be measured as acute and long-term effects f...